Agreement signedAgreed 20 Dec 2021

NightHawk Biosciences, Inc. /
Elusys Therapeutics, Inc.

NightHawk Biosciences, Inc. agrees to buy Elusys Therapeutics, Inc.

Price
$48.1m
Stage
Agreement signed
Source · 20 Dec 2021
01 / BuyerNightHawk Biosciences, Inc.
02 / TargetElusys Therapeutics, Inc.
01

What happened

NightHawk Biosciences, Inc. agreed to acquire Elusys Therapeutics, Inc. for approximately $48.1 million, according to a filing dated June 6, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Source

NightHawk Biosciences, Inc. agrees to buy Elusys Therapeutics, Inc.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.